AIFF insider plans 74,810-share sale on NASDAQ for $201,939.87
Rhea-AI Filing Summary
Firefly Neuroscience, Inc. (AIFF) notice shows a proposed sale of 74,810 common shares to be executed through Haywood Securities Inc. on 10/10/2025 on NASDAQ, with an aggregate market value of $201,939.87. The shares were acquired by the selling party on 08/12/2024 as merger consideration, totaling 1,636,990 shares received at that time. The filer reports one sale in the prior three months: 30,126 shares sold on 10/09/2025 for gross proceeds of $86,694.86. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Transaction disclosed under Rule 144, providing transparency on insider sales
- Securities were acquired via merger consideration on 08/12/2024, documenting acquisition source
Negative
- Planned sale of 74,810 shares will increase free float in the near term
- Recent prior sale of 30,126 shares on 10/09/2025 suggests continued disposition following the merger
Insights
Insider sale notice documents a modest block sale after a merger acquisition.
The document records a planned sale of 74,810 shares on 10/10/2025 through Haywood Securities Inc. at an aggregate market value of $201,939.87. The shares were acquired as merger consideration on 08/12/2024, showing disposal of securities received in that transaction.
Primary dependencies are standard Rule 144 transfer conditions and execution through the listed broker; monitoring execution timing and any additional near-term sales is helpful, given a recent sale of 30,126 shares on 10/09/2025.